Search

everythinglearnresearchcommunity

for

Search:↓

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

Alopecia causes smaller hair follicles and affects growth-related structures.

Cedrol may prevent hair loss caused by chemotherapy better than minoxidil.

Chemotherapy often causes hair loss in cancer patients, affecting their mental health, but scalp cooling can help prevent it.

Hair follicle studies suggest that maintaining telomere length could help treat hair loss and graying, but it's uncertain if mouse results apply to humans.

mTORC1 signaling needed for quick hair follicle recovery after radiation damage.

Autophagy is important for human hair growth and health.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Black seed oil significantly protects against hair loss from chemotherapy.

Environmental pollutants can damage hair health and cause hair loss.

Ketoconazole shampoo improves hair growth and reduces oil similarly to minoxidil in male pattern hair loss.

The document concludes that understanding hair follicle cell cycles is crucial for hair growth and alopecia research, and recommends specific techniques and future research directions.

The conclusion is that understanding how hair follicle stem cells live or die is important for maintaining healthy tissue and repairing injuries, and could help treat hair loss, but there are still challenges to overcome.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

The research provided new insights into the genetic factors contributing to hair loss and skin conditions by analyzing individual cells from the human scalp.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Blocking the Mitochondrial Pyruvate Carrier causes stress in hair follicles, which can be reduced by an ISR inhibitor.

The p75 neurotrophin receptor is important for hair follicle regression by controlling cell death.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

The CNC® prosthetic system improved body image in breast cancer patients with hair loss from chemotherapy but did not significantly change their psychological wellbeing.

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Temporary hair loss can occur after 5-fluorouracil treatment for keloids.

Different types of hair loss require specific treatments, and new treatments are being developed.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.